The professional's guide to product selection
An innovative Photodynamic Therapy (PDT) Machine featuring normal PDT, pulsed PDT for reduced treatment pain, compact daylight PDT when effective daylight is unavailable. It is used with a licenced photosensitiser, such as Metvix from Galderma or Ameluz from Biofrontera
A water-miscible cream containing clobetasone 17-butyrate 0.05% w/w, oxytetracycline 3.0% w/w as calcium oxytetracycline and nystatin 100,000 units per gram.
Tioconazole is an imidazole that is active against commonly occurring dermatophyte and yeast-like fungal species. It is fungicidal in murine models vs Candida spp., T. rubrum and T. mentacrophytes. In vitro, it is fungicidal to pathenogenic dermatophytes, yeasts and other fungi
Elasticated tubular garments with SoftSeam and 2-Way Stretch technology
An emollient cream which may be used for a wide variety of dry skin conditions. It contains white soft paraffin 10% w/w.
Ultralanum plain cream and ointment both contain the active ingredient fluocortolone, which is a type of medicine known as a topical corticosteroid. Corticosteroids are medicines used for reducing inflammation. When fluocortolone is applied to the skin it works by acting inside the skin cells to decrease the release of these inflammatory substances. This reduces swelling, redness and itch.
Ultraveen Itch Relief Cream synergistically combines 5% urea with Colloidal Oatmeal to provide rapid itch relief.
Rinvoq (upadacitinib) is a selective and reversible Janus kinase (JAK) inhibitor. JAKs are intracellular enzymes that transmit cytokine or growth factor signals involved in a broad range of cellular processes including inflammatory responses, hematopoiesis, and immune surveillance. The JAK family of enzymes contains four members, JAK1, JAK2, JAK3 and TYK2 which work in pairs to phosphorylate and activate signal transducers and activators of transcription (STATs). This phosphorylation, in turn, modulates gene expression and cellular function. JAK1 is important in inflammatory cytokine signals while JAK2 is important for red blood cell maturation and JAK3 signals play a role in immune surveillance and lymphocyte function.
Ustekinumab is a fully human IgG1κ monoclonal antibody that binds with specificity to the shared p40 protein subunit of human cytokines interleukin (IL)-12 and IL-23. Ustekinumab inhibits the bioactivity of human IL-12 and IL-23 by preventing p40 from binding to the IL-12Rβ1 receptor protein expressed on the surface of immune cells. Ustekinumab cannot bind to IL-12 or IL-23 that is already bound to IL-12Rβ1 cell surface receptors. Thus, ustekinumab is not likely to contribute to complement- or antibody-mediated cytotoxicity of cells with IL-12 and/or IL-23 receptors.